CLSI AUTO11-A2
IT Security of In Vitro Diagnostic Instruments and Software Systems; Proposed Standard, AUTO11A2Estandard by Clinical and Laboratory Standards Institute, 10/01/2014
CLSI NBS07-Ed1
Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1Estandard by Clinical and Laboratory Standards Institute, 03/01/2017
CLSI M51-A (R2018)
Method for Antifungal Disk Diffusion Susceptibility Testing of Filamentous Fungi; Approved Guideline, M51Astandard by Clinical and Laboratory Standards Institute, 01/01/2010
CLSI MM07-A2 (R2018)
Fluorescence In Situ Hybridization Methods for Clinical Laboratories; Approved Guideline--Second Edition, MM07A2Estandard by Clinical and Laboratory Standards Institute, 08/30/2013
CLSI H02-A5
Procedures for the Erythrocyte Sedimentation Rate Test; Approved Standard - Fifth Edition, H02A5standard by Clinical and Laboratory Standards Institute, 05/01/2011
CLSI POCT04-Ed3
Essential Tools for Implementation and Management of a Point-of-Care Testing Program, POCT04Ed3Estandard by Clinical and Laboratory Standards Institute, 06/01/2016
CLSI M48-A
Laboratory Detection and Identification of Mycobacteria; Approved Guideline, M48AEstandard by Clinical and Laboratory Standards Institute, 01/01/2008
CLSI VET04-A2 PK
Methods for Broth Dilution Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Approved Guideline, VET04AE, Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Second Informational Supplement,…
CLSI MM02A2
Immunoglobin and T-Cell Receptor Gene Rearrangement Assays; Approved Guideline, MM02-A2standard by Clinical and Laboratory Standards Institute, 08/01/2002
CLSI M57-Ed1
Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testingstandard by Clinical and Laboratory Standards Institute, 04/25/2016